Development of a SARS-COV-2 monoclonal antibody panel and its applicability as a reagent in high-throughput fluorescence reduction neutralization and immunohistochemistry assays
G. Mattoso, A. Cataneo, S. M. Raboni…·C. N. Duarte dos Santos
This study develops a high-throughput fluorescence reduction neutralization assay (FRNA) using monoclonal antibodies to measure SARS-CoV-2 neutralizing antibodies, showing strong correlation with standard PRNT while reducing time by 70%.